COVID-19 antibodies enable tissue-based detection of viral infection
HistoSure’s novel monoclonal COVID-19 antibodies developed to enable tissue-based detection of viral infection in human clinical samples have shown excellent
Read moreHistoSure’s novel monoclonal COVID-19 antibodies developed to enable tissue-based detection of viral infection in human clinical samples have shown excellent
Read morePharma giant Sanofi will spend €400 million annually towards a vaccines mRNA Center of Excellence, which will be the first
Read moreGERBU manufactures high-quality NADH – β-Nicotinamide adenine dinucleotide, a reducing agent for biochemical assays. NADH reagents are utilised in enzyme
Read moreGERBU manufactures high-purity β-Nicotinamide Adenine-dinucleotide Phosphate Disodium Salt (NADP-Na2, NADP disodium salt), an oxidising agent for biochemical assays. The ≥97%
Read moreGERBU manufactures high-purity NADPH Tetrasodium Salt (β-Nicotinamide Adenine Dinucleotide Phosphate reduced tetrasodium salt), a reducing agent for biochemical assays. The
Read moreGERBU manufactures high-quality β-Nicotinamide Adenine Dinucleotide (NAD+), free acid, oxidising agent, for biochemical assays. GERBU’s β-Nicotinamide Adenine Dinucleotide (NAD+), free
Read moreGuanidine Thiocyanate 4x crystallized, also known as Guanidinium Thiocyanate (GITC) is a chaotropic agent, which acts as a strong protein
Read moreGuanidine Hydrochloride (GuHCl) 4x crystallized is a strong chaotropic agent useful for the denaturation and subsequent refolding of proteins. GERBU’s
Read moreEli Lilly and Company and MiNA Therapeutics, a pioneer in RNA activation therapeutics, have announced a worldwide research partnership to
Read moreEvotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) revealed that it has invested in OxVax, a new immuno-oncology organization
Read more